The Expression of Interleukin-10 in Patients with Primary Ovarian Epithelial Carcinoma and in Ovarian Carcinoma Cell Lines

Author： Zhou J   Ye F   Chen H   Lv W   Gan N  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.35, Iss.3, 2007-05, pp. : 290-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Farletuzumab in Epithelial Ovarian Carcinoma

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3812-3815

Bentham Science Publishers

Access to resources Recommend Favorite

Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1904-1916

Bentham Science Publishers

Access to resources Recommend Favorite

Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway

By Lee Chung  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 548-557

Springer Publishing Company

Access to resources Recommend Favorite

Anatomic Site-Related Expression of Cancer-Associated Molecules in Ovarian Carcinoma

By  

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 109-120

Bentham Science Publishers

Access to resources Recommend Favorite

The Correlation between Plasma Fibrinogen Levels and the Clinical Features of Patients with Ovarian Carcinoma

By Ma Y   Qian Y   Lv W  

The Journal of International Medical Research, Vol. 35, Iss. 5, 2007-09 ,pp. : 678-684

Field House Publishing

Access to resources Recommend Favorite